The new Uhlmann bottle line uses Cremer technology for 100% counting accuracy and an inspection and rejection system for all critical quality parameters.
Jones Healthcare Group, a packaging and medication-dispensing solutions company, announced on June 29, 2020 that it is expanding its bottling capabilities by investing in a new, fully integrated Uhlmann bottle line.
With a filling speed of up to 150 bottles per minute, the bottle line uses Cremer technology for 100% counting accuracy and an inspection and rejection system for all critical quality parameters, a company press release said. It works with several bottle shapes, sizes, and constructions, with integrated cartoning and bundling technology.
“Our investments are driven by customer and market demand for flexible, innovative, and full-service packaging services that align with global regulatory requirements,” said Marty Quesnel, senior vice-president, Packaging Services, at Jones, in the press release. “Our new bottling capabilities complement our blistering, pouching, convenience vial filling, and secondary packaging services as well as our full serialization and aggregation solution for prescription medicines. No matter what packaging our healthcare clients need, we can deliver with speed and flexibility in a Health Canada and FDA-registered environment.”
“We are pleased to continue our partnership with world-class pharmaceutical equipment manufacturer Uhlmann to broaden our offering with leading bottling technology,” said Ron Harris, president and CEO, Jones, in the press release. “Our ongoing investment strengthens our support for healthcare clients as an integrated supply chain partner who delivers a range of regulated packaging services and components from concept to finished product.”
The new line will be installed at the company’s facility in Brampton, Ontario, Canada, and will be operational by next year.
Source: Jones Healthcare Group
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.